Retrospective Study on the Impact of Hepatitis B and Hepatitis C virus Infection on Hematopoietic Stem Cell Transplantation in Japan
スポンサーリンク
概要
著者
-
GONDO Hisashi
Department of Internal Medicine, Saga Prefectural Hospital Koseikan
-
MORISHIMA Yasuo
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
KODERA Yoshihisa
Department of Hematology, Japanese Red Cross Nagoya First Hospital
-
Kishimoto Yuji
The First Department Of Internal Medicine Kansai Medical University
-
GONDO Hisashi
First Dept. of Internal Medicine, Kyushu University
-
Harada Mine
Department Of Medicine And Biosystemic Science Kyushu University Graduate School Of Medical Sciences
-
Harada Mine
岡山大学 第2内科
-
Kagami Y
Department Of Hematology Japanese Red Cross Nagoya First Hospital
-
Kagami Yoshitoyo
名古屋大学医学部附属病院 病理部
-
HAMAGUCHI Motohiro
Department of Hematology, National Hospital Organization, Nagoya Medical Center
-
Hamaguchi M
Nagoya National Hospital Nagoya
-
Hamaguchi Motohiro
Department Of Hematology Clinical And Research Center National Hospital Organization Nagoya Medical
-
Kamiya Yoshikazu
Department Of Hematology Meitetsu Hospital
-
Harada Mine
九州大学 医学研究院病態修復内科学
-
Matsumoto-mishima Yuko
癌研究会癌化学療法センター 臨床研究部
-
YAMADA Hironori
Department of Hematology, Nagoya National Hospital
-
Gondo H
Department Of Internal Medicine Saga Prefectural Hospital Koseikan
-
Gondo Hisashi
Department Of Hematology Saga Prefectural Hospital Koseikan
-
Gondo Hisashi
Japan Society For Hematopoietic Cell Transplantation Adult Data Management Committee
-
Gondo Hisashi
First Dept. Of Internal Medicine Kyushu University
-
Gondo Hisashi
Department Of Hematology Hamanomachi Hospital
-
TAKEMOTO Yoshinobu
Second Department of Internal Medicine, Hyogo College of Medicine
-
Takemoto Yoshinobu
Second Department Of Internal Medicine Hyoho Medical University
-
YAMADA Hironori
Nagoya Ekisaikai Hospital
-
Hara M
Department Of Medicine And Biosystemic Science Kyushu University Graduate School Of Medical Science
-
Harada Mine
Department Of Internal Medicine Ii Okayama University Graduate School Of Medicine And Dentistry
-
Harada M
Chiba Univ. Chiba Jpn
-
Hidaka Michihiro
Department Of Internal Medicine Kumamoto Medical Center National Hospital Organization
-
Kodera Y
Department Of Internal Medicine Japanese Red Cross Nagoya First Hospital
-
Kodera Yoshihisa
Department Of Hematology Japanese Red Cross Nagoya First Hospital
-
Harada Mine
Second Department Of Internal Medicine Okayama University School Of Medicine
-
Kagami Yoshitoyo
Department Of Pathology School Of Medicine Kurume University
-
Hara Masamichi
Department Of Internal Medicine Kumamoto Medical Center National Hospital Organization
-
Morishima Yasuo
Department Of Hematology And Cell Therapy Aichi Cancer Center
-
Kawabata Yoshinari
Department Of Internal Medicine Iii Akita University School Of Medicine
-
Yamanishi Hiroaki
Department Of Hematology Nagoya National Hospital
-
Yamada Hironori
Department Of Applied Physics Faculty Of Engineering Hokkaido University
-
Yano Kunio
県西部浜松医療センター
-
Takemoto Yoshinobu
Second Department Of Internal Medicine Hyogo College Of Medicine
-
Kawabata Yoshinari
Division Of Hematology And Nephrology Department Of Internal Medicine Akita University School Of Med
-
Hara Masamichi
Ehime Prefectural Central Hospital Matsuyama Jpn
-
Hamaguchi M
Division Of Hematology Ehime Prefectural Central Hospital
-
KODERA Yoshihisa
Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine
関連論文
- Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia : results of the JALSG AML97 study
- Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
- Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Japan : a retrospective analysis of 1,057 cases from Kyushu Lymphoma Study Group
- Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin's lymphoma after rituximab therapy
- Progressive multifocal leukoencephalopathy in a patient with B-cell lymphoma during rituximab-containing chemotherapy : case report and review of the literature
- Stromal cells in bone marrow play important roles in pro-inflammatory cytokine secretion causing fever following bortezomib administration in patients with multiple myeloma
- Diffuse large B-cell lymphoma after transformation from low-grade follicular lymphoma : morphological, immunohistochemical, and FISH analyses
- Nocardia exalbida brain abscess in a patient with follicular lymphoma
- Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma
- Phase II study of tacrolimus and methotrexate for prophylaxis of acute graft-versus-host disease after HLA-A, B, and DRB1 genotypically mismatched unrelated bone marrow transplantation among Japanese patients
- Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission
- Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma
- Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
- Peripheral blood stem cell versus bone marrow transplantation from HLA-identical sibling donors in patients with leukemia : a propensity score-based comparison from the Japan Society for Hematopoietic Stem Cell Transplantation registry
- Reconstitution of HLA-A^*2402-Restricted Cytomegalovirus-Specific T-Cells following Stem Cell Transplantation
- Chronic Graft-versus-Host Disease following Varicella-Zoster Virus Infection in Allogeneic Stem Cell Transplant Recipients
- G-CSF does not Stimulate Leukemic Stem Cells in Vivo
- A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL
- Usefulness of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) for undiagnosed intra-abdominal lymphadenopathy
- Identification of four novel mutations in F5 associated with congenital factor V deficiency
- Reduced-intensity unrelated donor bone marrow transplantation for hematologic malignancies
- Epstein-Barr virus involvement is a predictive factor for the resistance to chemoradiotherapy of gastric diffuse large B-cell lymphoma
- Phase I study of radioimmunotherapy with an anti-CD20 murine radioimmunoconjugate (^Y-ibritumomab tiuxetan) in relapsed or refractory indolent B-cell lymphoma
- Durable Response but Prolonged Cytopenia after Cladribine Treatment in Relapsed Patients with Indolent non-Hodgkin's Lymphomas : Results of a Japanese Phase II Study
- t(11 ; 18)-Bearing Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma Responding to Cladribine
- Two Entities of Precursor T-Cell Lymphoblastic Leukemia/Lymphoma Based on Radiologic and Immunophenotypic Findings
- Primary Mediastinal Large B-Cell Lymphoma : A Single-Institution Clinical Study in Japan
- EBV-Positive Burkitt Lymphoma as a Late-Onset Posttransplantion Lymphoproliferative Disorder after Allogeneic Stem Cell Transplantation
- Primary Hepatic Low-Grade B-Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue Type : A Case Report and Review of the Literature
- Successful Allogeneic Bone Marrow Transplantation in a Case of Adult Precursor B-Lymphoblastic Lymphoma
- Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
- Mantle cell lymphoma shows three morphological evolutions of classical, intermediate, and aggressive forms, which occur in parallel with increased labeling index of cyclin D1 and Ki-67
- The clinical characteristics of CD7^+ CD56^+ acute myeloid leukemias other than M0
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
- Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission : a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group
- BMI-1 Is Highly Expressed in M0-Subtype Acute Myeloid Leukemia
- Phase I Trial of FLAGM with High Doses of Cytosine Arabinoside for Relapsed, Refractory Acute Myeloid Leukemia : Study of the Japan Adult Leukemia Study Group (JALSG)
- Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma
- Primary Hepatic Follicular Lymphoma : A Case Report and Discussion of Chemotherapy and Favorable Outcomes
- Expression profiling analysis of the CD5^+ diffuse large B-cell lymphoma subgroup : Development of a CD5 signature
- Characterization of target genes at the 2p15-16 amplicon in diffuse large B-cell lymphoma
- Randomized phase II study of concurrent and sequential rituximab and CHOP chemotherapy in untreated indolent B-cell lymphoma
- Senile Epstein-Barr Virus-Associated B-Cell Lymphoproliferative Disorders : a Mini Review
- CD56/NCAM-Positive Langerhans Cell Sarcoma : A Clinicopathologic Study of 4 Cases
- Phenotypic analysis of peripheral T/NK cell lymphoma : Study of 408 Japanese cases with special reference to their anatomical sites
- Pilot Phase I/II Study of New Salvage Therapy(CHASE) for Refractory or Relapsed Malignant Lymphoma
- Efficacy and Safety of Imatinib Mesylate for Patients in the First Chronic Phase of Chronic Myeloid Leukemia : Results of a Japanese Phase II Clinical Study
- Prognostic Significance of CD7^+CD56^+ Phenotype and Chromosome 5 Abnormalities for Acute Myeloid Leukemia M0
- Morphological spectrum of cyclin D1-positive mantle cell lymphoma : Study of 168 cases
- Current Status of Hematopoietic Cell Transplantation for Adult Patients with Hematologic Diseases and Solid Tumors in Japan
- Effective and Safe Interferon Treatment for Japanese Patients With Chronic Myelogenous Leukemia Relapse After Bone Marrow Transplantation
- Comparison of genetic aberrations in CD10^+ diffused large B-cell lymphoma and follicular lymphoma by comparative genomic hybridization and tissue-fluorescence in situ hybridization
- MUM1/IRF4 Expression Is an Unfavorable Prognostic Factor in B-Cell Chronic Lymphocytic Leukemia(CLL)/Small Lymphocytic Lymphoma(SLL)
- CD34^+-Selected Autologous Peripheral Blood Stem Cell Transplantation Conditioned With Total Body Irradiation for Malignant Lymphoma: Increased Risk of Infectious Complications
- Assessment of Prognostic Factors in Follicular Lymphoma Patients
- Infrequent BCL10 Mutations in B-Cell Non-Hodgkin's Lymphomas
- Blast crisis of chronic myelogenous leukemia exhibiting immunophenotypic features of a myeloid/natural killer cell precursor
- A high dose chemoradiotherapy and peripheral blood stem cell support combined with the CD34^+-selection method in cyclin D1^+-mantle cell lymphoma
- Somatic Hypermutations in the V_H Segment of Immunoglobulin Genes of CD5-positive Diffuse Large B-Cell Lymphomas
- Safety and efficacy of rasburicase (SR29142) in a Japanese phase II study
- Re-Treatment of Relapsed Indolent B-Cell Lymphoma With Rituximab
- Phase I/II study of tandem high-dose chemotherapy with autologous peripheral blood stem cell transplantation for advanced multiple myeloma
- Reduced-Intensity Hematopoietic Stem Cell Transplantation for a Patient with Myelodysplastic Syndrome and Chronic Obstructive Pulmonary Disease
- Interferon-α treatment of acute lymphoblastic leukemia relapse after unrelated bone marrow transplantation
- Granulocyte colony-stimulating factor-combined marrow-ablative chemotherapy and autologous blood cell transplantation for the treatment of patients with acute myelogenous leukemia in first remission
- Long-term Follow-up of 14 Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia following Autologous Bone Marrow Transplantation in First Complete Remission
- A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial
- Impact of Cytogenetics on Outcome of Stem Cell Transplantation for Acute Myeloid Leukemia in First Remission : A Large-Scale Retrospective Analysis of Data from the Japan Society for Hematopoietic Cell Transplantation
- Quality of Life in Adult Patients After Stem Cell Transplantation
- Cytotoxic large T-cell lymphoma with fulminant clinical course,CD8^+ and CD56^-phenotype, and its relation to Epstein-Barr virus:a report of two cases
- Successful Nonmyeloablative Bone Marrow Transplantation for Leukocyte Adhesion Deficiency Type I from an Unrelated Donor
- Decreased risk of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in patients with the 5,10-methylenetetrahydrofolate reductase 677TT genotype
- Serologically HLA-DR-Mismatched Unrelated Donors Might Provide a Valuable Alternative in Allogeneic Transplantation : Experience from a Single Japanese Institution
- Stable Engraftment after a Conditioning Regimen with Fludarabine and Melphalan for Bone Marrow Transplantation from an Unrelated Donor
- Severe Hypercholesterolemia Associated with Decreased Hepatic Triglyceride Lipase Activity and Pseudohyponatremia in Patients after Allogeneic Stem Cell Transplantation
- Quality of Life in Adult Patients after Bone Marrow Transplantation
- Serum thrombopoietin level after allogeneic bone marrow transplantation: possible correlations with platelet recovery, acute graft-versus-host disease and hepatic veno-occlusive disease
- MLL Gene Rearrangement in t(9;11) Acute Myelogenous Leukemia With Minimal Myeloid Differentiation (FAB Subtype M0)
- Twenty Years' Experience in Allogeneic Hematopoietic Stem Cell Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Nagoya Blood and Marrow Transplantation Group
- Epstein-Barr virus nuclear antigen 1-specific CD4^+ T cells directly kill Epstein-Barr virus-carrying natural killer and T cells
- Aberrant expression of BCL2A1-restricted minor histocompatibility antigens in melanoma cells : application for allogeneic transplantation
- Minor histocompatibility antigens as targets for immunotherapy using allogeneic immune reactions
- Late Relapse of Acute Myelogenous Leukemia Followed by Epstein-Barr Virus-Associated Lymphoproliferative Disease 11 Years after Allogeneic Bone Marrow Transplantation
- Unification of Hematopoietic Stem Cell Transplantation Registries in Japan and Establishment of the TRUMP System
- Unrelated Donor Marrow Transplantation for Congenital Immunodeficiency and Metabolic Disease : An Update of the Experience of the Japan Marrow Donor Program
- Growth Inhibition of CD20-positive B Lymphoma Cell Lines by IDEC-C2B8 Anti-CD20 Monoclonal Antibody
- Uncommon case of chronic myeloid leukemia with multiple myeloma
- Appearance of Thyroid Stimulating and Blocking Immunoglobulins after Bone Marrow Transplantation : Presentation of Two Contrasting Cases
- Retrospective Study on the Impact of Hepatitis B and Hepatitis C virus Infection on Hematopoietic Stem Cell Transplantation in Japan
- Successful Treatment of Diffuse Large B-cell Lymphoma Following Waldenstrom's Macroglobulinemia with CHOP Chemotherapy Followed by Combination Therapy of CHOP with Rituximab
- Influenza-induced Rhabdomyolysis after Autologous Peripheral Blood Stem Cell Transplantation for Malignant Lymphoma
- Leukemic transformation of Langerhans cell sarcoma
- Unrelated bone marrow transplantation from the National Marrow Donor Program
- Development of novel humanized anti-CD20 antibodies based on affinity constant and epitope
- Potential efficacy of the oral histone deacetylase inhibitor vorinostat in a phase I trial in follicular and mantle cell lymphoma
- Prognostic impact of immunohistochemical biomarkers in diffuse large B-cell lymphoma in the rituximab era
- Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma
- Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab
- Early treatment of CMV antigenemia with ganciclovir for prevention of fatal CMV disease in patients receiving marrow from HLA-matched unrelated donors
- Randomized phase II study of concurrent and sequential combinations of rituximab plus CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) chemotherapy in untreated indolent B-cell non-Hodgkin lymphoma : 7-year follow-up results